Eton Pharmaceuticals, Inc. 已签署一项授权协议,成功从Pierre Fabre Medicament Sas公司收购了Hemangeol口服溶液在美国的独家销售权。此次交易将进一步加强Eton在美国医药市场的产品布局。
Eton Pharmaceuticals, Inc. 已签署一项授权协议,成功从Pierre Fabre Medicament Sas公司收购了Hemangeol口服溶液在美国的独家销售权。此次交易将进一步加强Eton在美国医药市场的产品布局。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.